India`s Aurobindo Pharma Ltd posted a better-than-expected 29 percent rise in quarterly profit on Thursday, helped by higher sales at its formulations business in the United States.
Net profit after taxes and non-controlling interest was 7.81 billion rupees ($120.22 million) in the second quarter ended Sept. 30, compared with 6.06 billion rupees a year earlier, the Hyderabad-headquartered drugmaker said in a statement.
Analysts on average had expected a profit of 6.87 billion rupees, Thomson Reuters data showed.
U.S. formulations sales, which accounted for 47 percent of total revenue, rose 21 percent to 20.98 billion rupees due to new product launches and higher sales of existing products, the company said.
Revenue from its Active Pharmaceuticals Ingredients (API) business edged 0.4 percent up.($1 = 64.9650 Indian rupees)
(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
80% return in one year: Brokerage suggests buying this Maharatna PSU stock for 2-3 days, check target
Lok Sabha elections 2024 Phase 4: Voting date, timing, states, union territories, seats, key candidates and constituencies | LS Polls
5 investment schemes that provide monthly pension to senior citizens fixed deposit fds savings scss guaranteed return atal pension yojana post office monthly income swps mutual fund
HPCL dividend 2024: OMC Hindustan Petroleum Corporation announces Rs 16.50 dividend, check record date
Akshaya Tritiya bank holiday or not Basava Jayanti 2024 festival date Banks closed or open tomorrow may 10 friday check out state-wise full list
09:51 PM IST